April 3, 2020 March 17, 2020 March 4, 2020 October 7, 2019 
FRANKLIN LAKES, N.J. and MORRISVILLE, N.C., March 31, 2020 — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioMedomics, a privately held, North Carolina-based
Yesterday, March 16, the FDA updated its “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency” document. The document can be downloaded
Click here to read the latest story about BioMedomics development of rapid immunoassay test for COVID-19 novel coronavirus on WRAL TechWire.
BioMedomics is the first company to publish a journal article about the development and launch of a rapid COVID-19 test. Read it in the Journal
Morrisville, NC, USA – BioMedomics, a leader in innovative clinical diagnostics products that address global healthcare needs, participated in several sickle cell screening events in
Morrisville, NC, USA – BioMedomics, a leader in innovative clinical diagnostics products that address global healthcare needs, proudly announced a partnership today with Ade Adebisi,
Publisher Wiley-Blackwell released a new book in May entitled “Revolutionizing Tropical Medicine: Point-of-Care Tests, New Imaging Technologies and Digital Health” by authors/editors Kerry Atkinson and
A study published this month in the journal BMC Hematology, evaluated the performance of BioMedomics’ Sickle SCAN rapid test under real-world environmental conditions in two